# SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease

> **NCT00257543** · EARLY_PHASE1 · TERMINATED · sponsor: **Emory University** · enrollment: 3 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **PROCEDURE:** Alternative donor bone marrow and cord blood

## Key facts

- **NCT ID:** NCT00257543
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** lack of enrollment
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257543, "SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00257543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*